Keywords
Disability Evaluation
Patient Discharge
How to Cite
Abstract
The municipality of Buriticupu presents the epidemiological indicators are classified as hiperendêmico for leprosy. Taking into account the potential of disease in causing physical disability and limitations of psychosocial nature was developed a study to characterize the degree of functional impairment, physical activity and social participation of individuals after high for cure. Thestudy, transversal and descriptive, was developed during the period from June to December 2010 in a sample of 69 individuals who had received the treatment between 2007 and 2009. Simplified evaluation was made of neural function, applying the scale SALSA to characterize the limitation of activity and awareness of risk and of the scale of participation to characterize the restriction on the individual’s social participation, in addition to the calculation of the OMP score. It was identified a predominantly male population, economically active age group and occupation related to demands for physical effort, highlighted by a farmer. The percentage of 76.8% of patients had no physical disabilities, while 59.4% had no limitation of activity. There was no perception of risk of suffering traumatic injuries by 69.6% of individuals, while 72.5% of individuals showed no significant constraint to social participation. However, the percentage which showed changing reflects the necessity of improving on discharging attention at the municipality.
References
2 Silva AR, Portela EGL, Matos WB, Silva CCB, Gonçalves EGR. Hanseníase no município de Buriticupu, Estado do Maranhão: busca ativa na população estudantil. Rev Soc Bras Med Trop. 2007;40(6):657-60.
3 Silva AR, Matos WB, Silva CCB, Gonçalves EGR. Hanseníase no município de Buriticupu, Estado do Maranhão: busca ativa de casos na população adulta. Rev Soc Bras Med Trop. 2010;43(6):691-4.
4 Silva AR, Santos ARR, Santos GMC, Silva VEB, Gonçalves EGR. Leprosy in Buriticupu, State of Maranhão: active search in the general population. Rev Soc Bras Med Trop. 2012;45(2):199-202.
5 Aquino DM, Caldas AJ, Silva AA, Costa JML. Perfil dos pacientes com hanseníase em área hiperendêmica da Amazônia do Maranhão. Rev Soc Bras Med Trop. 2003;36(1):56-64.
6 Lockwood DNJ, Suneetha S. Leprosy: too complex a disease for a simple elimination paradigm. Bull World Health Organ. 2005 Mar;83(3):230-5.
7 Job CK, Path FRC. O comprometimento neural na hanseníase. Hansen Int. 1989;14(1):50-8.
8 Shetty VP, Mistry NF, Antia NH. Current understanding of leprosy as a peripheral nerve disorder: significance of involvement of peripheral nerve in Leprosy. Indian J Lepr. 2000;72(3):339-50.
9 Srinivasan H. Disability, deformity and rehabilitation. In: Hastings RC. Leprosy. 2nd. New York: Churchill Livingstone; 1994. p. 411-47.
10 Organisation Mondiale de la Santé (OMS). Comité OMS d’experts de la Lepre [Internet]. Geneve: Organisation Mondiale de la Santé; 1988. [citado em 2010 nov. 10]. Disponível em:http://whqlibdoc.who.int/trs/WHO_TRS_768_fre.pdf
11 Suárez GRE. Notas sobre la epidemiologia de la lepra. Washington: Organización Panamericana de la Salud / Organización Mundial de la Salud; 1989. p. 23-8. (PNSP 89-42).
12 Goulart IB, Dias CM, Oliveira ACS, Silva AA, Alves RR, Quaresemin CR, et al. Grau de incapacidade: indicador de prevalência oculta e qualidade do programa de controle da hanseníase em um Centro de Saúde - Escola no Município de Uberlândia - MG. Hansen Int. 2002;27(1):5-13.
13 Sauderson P. The epidemiology of reactions and nerve damage. Lepr Rev. 2000 Dec.;71(Suppl):106-10.
14 Ministério da Saúde (BR), Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica. Manual de Prevenção de Incapacidades. 3ed. Brasília: Ministério da Saúde; 2008.
15 World Health Organization (WHO). International Classification of Functioning,Disability and Health. [place unknown]: ICF; 2001.
16 Escala SALSA: pacote de teste Beta - versão 1.0. 2004. [citado em 2010 out. 15]. Disponível em: http://www.almbrasil.com.br/arquivos/Escala%20SALSA.doc
17 Participation Scale Users. Manual, 4.6. 2005. [citado em 2010 nov. 10]. Disponível em: http://www.leprastichting.nl/assets/infolep/Participation%20Scale%20Users%20Manual%20v.4.6.pdf
18 Salsa Collaborative Study Gro up. The development of a short questionnaire for screening of activity limitation and safety awareness (SALSA) in clients affected by leprosy or diabetes. Disabil Rehabil. 2007 May 15;29(9):689-700.
19 Lana FCF, Davi RF, Lanza FM, Amaral EP. Detecção da hanseníase e Índice de Desenvolvimento Humano dos municípios de Minas Gerais, Brasil. Rev Eletr Enf. 2009;11(3):539-44.
20 Longo JDM, Cunha RV. Perfil clínico-epidemiológico dos casos de hanseníase atendidos no Hospital Universitário em Campo Grande, Mato Grosso do Sul, de janeiro de 1994 a julho de 2005. Hansen Int. 2006;31(1):9-14.
21 Araújo RRDF, Oliveira MHP. A irregularidade dos portadores de hanseníase ao serviço de saúde. Hansen Int. 2003;28(1):59-64.
22 Croft RP, Nicholls PG, Steyerberg EW, Richardus JH, Cairns W, Smith S. A clinical prediction rule for nerve function impairment in leprosy patients. Lancet. 2000 May 6;355(9215):1603-6.
23 Barbosa JC, Ramos NA Junior, Alencar MJF, Castro CGJ. Pós-alta em hanseníase no Ceará: limitação da atividade funcional, consciência de risco e participação social. Rev Bras Enferm. 2008;61(esp):727-33.
24 Stucki G, Reinhardt JD, Grimby G, Melvin J. O desenvolvimento da pesquisa em funcionalidade humana e reabilitação a partir de uma
This work is licensed under a Creative Commons Attribution 4.0 International License.
Downloads
